Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population‐based study
Open Access
Abstract
BACKGROUND To the best of the authors' knowledge, few population‐based studies to date have examined the use of BRCA1/2 testing or patterns of physician recommendations for genetic testing among women diagnosed with breast cancer. The objective of the current study was to evaluate the rates and predictors of physician recommendation for BRCA1/2 testing among patients with breast cancer. METHODS Women aged 18 years to 64 years who were diagnosed with invasive breast cancer in 2007 were identified from the Pennsylvania Cancer Registry and mailed a survey regarding their family history of cancer, physician treatment recommendations, and BRCA1/2 testing. Of the 4009 women who were sent surveys, 2258 responded (56%). Based on age at diagnosis and family history, women were categorized as being at high, moderate, or low risk of BRCA1/2 mutations. RESULTS Nearly 25% of the participants were classified as being at high risk of carrying a BRCA1/2 mutation based on their age at the time of breast cancer diagnosis and family history of breast and/or ovarian cancer. Physician recommendations for BRCA1/2 testing were found to be strongly associated with risk of carrying a mutation, with 53% of high‐risk women reporting a testing recommendation compared with 9% of low‐risk women. In addition, physician recommendations were strongly correlated with the use of testing in all risk groups. Among high‐risk women, the lack of a recommendation for BRCA1/2 testing was more common among older, low‐income, and employed women. CONCLUSIONS Although BRCA1/2 testing recommendations appear to be appropriately correlated with mutation risk, a significant percentage of patients with breast cancer who meet criteria for BRCA1/2 testing may not receive a recommendation for such testing from their health care providers. Cancer 2013;119:3596–3603. © 2013 American Cancer Society.Keywords
This publication has 25 references indexed in Scilit:
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutationsJournal of Clinical Oncology, 2010
- Genetic testing in young women with breast cancer: results from a Web-based surveyAnnals of Oncology, 2009
- Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2009
- The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsBritish Journal of Cancer, 2008
- Factors Determining Dissemination of Results and Uptake of Genetic Testing in Families with Known BRCA1/2 MutationsGenetic Testing, 2008
- Referral and Experience with Genetic Testing Among Women with Early Onset Breast CancerGenetic Testing, 2005
- Knowledge, Attitudes, and Utilization of BRCA1/2 Testing among Women with Early-Onset Breast CancerGenetic Testing, 2005
- Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study GroupJournal of Clinical Oncology, 2004
- What Does My Doctor Think? Preferences for Knowing the Doctor's Opinion Among Women Considering Clinical Testing for BRCA1 / 2 MutationsGenetic Testing, 2002